From: PI3 kinase mutations and mutational load as poor prognostic markers in diffuse glioma patients
 | Grade II | Grade III | Grade IV | P | P II v. III |
---|---|---|---|---|---|
Overall | 39.6 ± 12.5 (137) | 45.6 ± 13.5 (144) | 61.3 ± 13 (261) | <0.0001 |  |
IDH1/IDH2 | 39.6 ± 12.3 (127) | 42 ± 12.1 (102) | 39.6 ± 15.7 (13) | 0.32 | 0.14 |
CIC/FUBP1 | 42.3 ± 13.4 (37) | 48 ± 10.8 (26) |  | 0.065 | 0.065 |
LOH 1p19q | 42 ± 12.4 (42) | 49.4 ± 11.8 (32) |  | 0.012 | 0.012 |
ATRX | 37.4 ± 11.9 (67) | 38.1 ± 11.3 (51) | 41.6 ± 17.2 (14) | 0.30 | 0.74 |
TP53 | 37.2 ± 11.8 (71) | 39.9 ± 11.7 (74) | 59.2 ± 15.5 (78) | <0.0001 | 0.18 |
EGFR |  | 61.7 ± 7.5 (15) | 61.2 ± 11.7 (69) | 0.84 |  |
PTEN |  | 56.8 ± 10.5 (12) | 62.8 ± 11.9 (80) | 0.092 |  |
alt 7/10 | 49.7 ± 8.3 (3) | 59.4 ± 6.8 (26) | 62.8 ± 10.8 (185) | 0.015 |  |
NF1 | 51 ± 18.4 (3) | 43.7 ± 12.7 (14) | 64.4 ± 13.2 (27) | 0.00050 |  |